From USA Today:
Long-term use of a popular class of oral diabetes drugs doubles the risk of bone fractures in women with type 2 diabetes, a new study reports.
According to researchers at Wake Forest University School of Medicine who reviewed 10 previous drug trials, for every 20 women in their 70s with type 2 diabetes who took thiazolidinediones — rosiglitgizone (brand name Avandia) and pioglitazone (brand name Actos) — for at least one year, one of them has a chance of suffering a fracture. In women in their mid-50s, the figure equals one fracture in every 55 women. That's more than double the normal risk for those age groups. ...more
Tuesday, December 09, 2008
Diabetes drugs double women's fracture risk
Labels:
Actos,
adverse drug reactions,
Avandia,
pioglitazone,
rosiglitazone
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment